Literature DB >> 27860286

Trends in Off-Label Prescribing of Sedatives, Hypnotics and Antidepressants among Children and Adolescents - A Danish, Nationwide Register-Based Study.

Eva Skovslund Nielsen1, Lotte Rasmussen2, Maja Hellfritzsch2, Per Hove Thomsen3, Mette Nørgaard4, Torben Laursen1.   

Abstract

In recent years, psychotropic drug use among children and adolescents in Europe and USA has increased. However, the majority of psychotropic drugs are not formally approved for use in children and adolescents, and consequently, use is often off-label. The objectives were to describe time trends in off-label prescribing rates and the most commonly used types of psychotropic drugs by age and gender in Danish children and adolescents. Using the Register of Medicinal Product Statistics, we identified all prescriptions for sedatives, hypnotics and antidepressants filled for children and adolescents in 2006-2012. Information on diagnoses was obtained from the Danish National Registry of Patients and allowed classification of prescriptions as either on- or off-label. We identified 186,831 prescriptions filled for 29,851 children and adolescents: 88.0% of these were classified as off-label. During 2006-2012, off-label rates for sedatives and hypnotics increased significantly, except for prescriptions for girls aged 15-17 years [range 24.1-98.2% (girls), 31.9% to 99.0% (boys)]. In the same period, the number of registered melatonin prescriptions (all off-label) increased expansively. For antidepressants, we found decreasing trends in off-label rates over time [range 94.5-65.6% (girls), 93.8-71.2% (boys)]. Off-label prescribing of psychotropic drugs to Danish children and adolescents is common. Off-label rates for sedatives and hypnotics increased in the period of 2006-2012, whereas off-label rates for antidepressants declined. Off-label rates might be underestimated and should be considered a conservative estimate.
© 2016 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27860286     DOI: 10.1111/bcpt.12706

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  7 in total

1.  Melatonin use among children, adolescents, and young adults: a Danish nationwide drug utilization study.

Authors:  Mette Bliddal; Helene Kildegaard; Lotte Rasmussen; Martin Ernst; Poul Jørgen Jennum; Stine Hasling Mogensen; Anton Pottegård; Rikke Wesselhoeft
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-07-06       Impact factor: 4.785

2.  Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10-year population-based study.

Authors:  Ainhoa Gómez-Lumbreras; Ana Garcia Sangenis; Oriol Prat Vallverdú; Anna Gatell Carbó; Cristina Vedia Urgell; Laura Gisbert Gustemps; Xavier Bruna Pérez; Antoni Ramos Quiroga; Rosa Morros Pedrós
Journal:  Psychopharmacology (Berl)       Date:  2021-03-10       Impact factor: 4.530

3.  Drug information center: challenges of the research process to answer enquiries in hospital pharmaceutical practices.

Authors:  Damiana da Rocha Vianna Flôres; Alexandre Augusto de Toni Sartori; Julia Borges Antunes; Alessandra Nunes Pinto; Julia Pletsch; Tatiane da Silva Dal Pizzol
Journal:  Eur J Hosp Pharm       Date:  2018-03-22

4.  "Include me if you can"-reasons for low enrollment of pediatric patients in a psychopharmacological trial.

Authors:  Larissa Niemeyer; Konstantin Mechler; Jan Buitelaar; Sarah Durston; Bram Gooskens; Bob Oranje; Tobias Banaschewski; Ralf W Dittmann; Alexander Häge
Journal:  Trials       Date:  2021-03-01       Impact factor: 2.279

5.  Pediatric use of prescribed melatonin in Sweden 2006-2017: a register based study.

Authors:  Elin E Kimland; Carola Bardage; Julius Collin; Anders Järleborg; Rickard Ljung; Anastasia N Iliadou
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-07-22       Impact factor: 4.785

6.  Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study.

Authors:  Anna Sidorchuk; Kayoko Isomura; Yasmina Molero; Clara Hellner; Paul Lichtenstein; Zheng Chang; Johan Franck; Lorena Fernández de la Cruz; David Mataix-Cols
Journal:  PLoS Med       Date:  2018-08-07       Impact factor: 11.069

7.  Use of Psychotropic Drugs among Children and Adolescents with Autism Spectrum Disorders in Denmark: A Nationwide Drug Utilization Study.

Authors:  Lotte Rasmussen; Niels Bilenberg; Martin Thomsen Ernst; Sidsel Abitz Boysen; Anton Pottegård
Journal:  J Clin Med       Date:  2018-10-10       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.